ALPLApharma and Inden Pharma at Pharmapack - Successful collaboration and exciting prospects
The partnership between ALPLApharma, the pharmaceutical division of ALPLA, and Inden Pharma in their joint venture has already proven successful within less than a year, opening new opportunities in a challenging market. With an expanded product range and enhanced services, the teams look forward to the challenges and opportunities that 2024 will bring. On January 24th and 25th, 2024, visitors can discover both new and existing products at Pharmapack in Paris.
ALPLApharma and Inden Pharma will exhibit together at Pharmapack 2024 fair in Paris from January 24th to 25th.
Walter Knes, Managing Director of ALPLApharma, shares his enthusiasm for the partnership: "Collaborating daily with our colleagues at Inden within the joint venture has been incredibly rewarding. In such a short time, we are already benefiting from their deep expertise and extensive experience in the pharmaceutical market."
Juan Guillem, Managing Director of Inden Pharma, echoes this enthusiasm: "We greatly value the global network and expertise of ALPLA and are proud to be part of the Family of Pioneers. Our shared experience and knowledge form a strong foundation for growth and innovation."
Looking ahead, the partners plan to pursue further global acquisitions to strengthen their presence and better serve customers worldwide.
Highlights at Pharmapack 2024
A key event for the partnership in 2024 will be their participation in the Pharmapack trade fair in Paris, taking place from January 24th to 25th. Visitors will be welcomed at their joint booth, where they will introduce new products, including the CRC Cap 36 Silicagel. This innovative tamper-evident (TE) closure with child-resistant (CRC) features integrates a desiccant (silica gel) with a capacity ranging from 1.2 g to 4.2 g in each stopper. Paired with perfectly matched bottles from 20 ml to 500 ml, this solution offers versatility and innovation in packaging.
At Pharmapack, the JV ALPLA INDEN Pharma is presenting a new tamper-evident closure with child-resistant features and integrated desiccant.
Additionally, the partners present SafePha, an innovative anti-counterfeiting technology for pharmaceutical packaging that offers numerous benefits. The holographic elements of SafePha deter counterfeiters and provide aesthetic appeal. Each packaging also includes a unique QR code for reliable product authentication, promoting digital patient communication, trust, and brand loyalty. Furthermore, SafePha is cost-effective and scalable without additional expenses.
Christian Hehle, Sales Director at ALPLApharma, along with his colleagues, will present the continually growing portfolio at Pharmapack, emphasizing an important aspect: "At Pharmapack, we showcase our steadily expanding portfolio, always in harmony with the theme of sustainability. This orientation underscores our commitment to actively contribute to a sustainable future."
About the JV ALPLApharma and Inden Pharma
In March 2023, ALPLApharma and Inden Pharma announced their joint venture, enhancing their presence in the pharmaceutical market with cutting-edge packaging solutions. The collaboration offers a diverse catalog of over 300 products.
Leveraging their extensive expertise as industry leaders and global players, the partners bring comprehensive knowledge and experience to the pharmaceutical sector, with production facilities in Greece, Poland, Spain, and Germany.
Join us at Pharmapack on January 24th and 25th, 2024, at Booth D43, and discover our secure and sustainable packaging solutions for pharmaceutical products!
Do you like our texts? Perhaps even so much that you want to use them in your own media? Then please get in touch with us beforehand!